Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 9/3034% above fair value
$97.90−0.10 (-0.10%)
Close on Nov 12, 2026Market cap $77.82BP/E 38.4Yield 2.12%
Colgate Palmolive total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Colgate Palmolive's total debt was $7.18B at Sep 30, 2026. For fiscal 2025 it was $7.99B, up 0.6% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $8.76B in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.99B | +0.6% |
| FY2024 | Dec 31, 2024 | $7.94B | -3.6% |
| FY2023 | Dec 31, 2023 | $8.24B | -5.9% |
| FY2022 | Dec 31, 2022 | $8.76B | +21.5% |
| FY2021 | Dec 31, 2021 | $7.21B | -1.9% |
| FY2020 | Dec 31, 2020 | $7.34B | -3.2% |
| FY2019 | Dec 31, 2019 | $7.59B | +19.4% |
| FY2018 | Dec 31, 2018 | $6.35B | -3.2% |
| FY2017 | Dec 31, 2017 | $6.57B | +0.7% |
| FY2016 | Dec 31, 2016 | $6.52B | -0.4% |
| FY2015 | Dec 31, 2015 | $6.54B | +6.7% |
| FY2014 | Dec 31, 2014 | $6.13B | +8.6% |
| FY2013 | Dec 31, 2013 | $5.64B | +9.0% |
| FY2012 | Dec 31, 2012 | $5.18B | +8.4% |
| FY2011 | Dec 31, 2011 | $4.78B | +41.5% |
| FY2010 | Dec 31, 2010 | $3.38B | +7.3% |
| FY2009 | Dec 31, 2009 | $3.15B | -14.4% |
| FY2008 | Dec 31, 2008 | $3.68B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.18B | -1.7% |
| Q2 FY2026 | Jun 30, 2026 | $7.82B | +9.5% |
| Q1 FY2026 | Mar 31, 2026 | $7.94B | -4.0% |
| Q4 FY2025 | Dec 31, 2025 | $7.99B | +0.6% |
| Q3 FY2025 | Sep 30, 2025 | $7.31B | -7.9% |
| Q2 FY2025 | Jun 30, 2025 | $7.14B | -12.5% |
| Q1 FY2025 | Mar 31, 2025 | $8.27B | +1.2% |
| Q4 FY2024 | Dec 31, 2024 | $7.94B | -3.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.93B | -8.9% |
| Q2 FY2024 | Jun 30, 2024 | $8.17B | -9.0% |
| Q1 FY2024 | Mar 31, 2024 | $8.17B | -8.0% |
| Q4 FY2023 | Dec 31, 2023 | $8.24B | -5.9% |
| Q3 FY2023 | Sep 30, 2023 | $8.71B | +5.8% |
| Q2 FY2023 | Jun 30, 2023 | $8.97B | +12.5% |
| Q1 FY2023 | Mar 31, 2023 | $8.89B | +16.9% |
| Q4 FY2022 | Dec 31, 2022 | $8.76B | +21.5% |
| Q3 FY2022 | Sep 30, 2022 | $8.23B | +7.0% |
| Q2 FY2022 | Jun 30, 2022 | $7.97B | +0.1% |
| Q1 FY2022 | Mar 31, 2022 | $7.60B | +0.3% |
| Q4 FY2021 | Dec 31, 2021 | $7.21B | -1.9% |
| Q3 FY2021 | Sep 30, 2021 | $7.69B | +6.4% |
| Q2 FY2021 | Jun 30, 2021 | $7.96B | +11.5% |
| Q1 FY2021 | Mar 31, 2021 | $7.58B | -0.2% |
| Q4 FY2020 | Dec 31, 2020 | $7.34B | -3.2% |
| Q3 FY2020 | Sep 30, 2020 | $7.23B | -5.5% |
| Q2 FY2020 | Jun 30, 2020 | $7.14B | +7.5% |
| Q1 FY2020 | Mar 31, 2020 | $7.59B | +14.0% |
| Q4 FY2019 | Dec 31, 2019 | $7.59B | +19.4% |
| Q3 FY2019 | Sep 30, 2019 | $7.65B | +17.3% |
| Q2 FY2019 | Jun 30, 2019 | $6.64B | +1.9% |
| Q1 FY2019 | Mar 31, 2019 | $6.66B | +1.6% |
| Q4 FY2018 | Dec 31, 2018 | $6.35B | -3.2% |
| Q3 FY2018 | Sep 30, 2018 | $6.52B | -0.0% |
| Q2 FY2018 | Jun 30, 2018 | $6.52B | +0.2% |
| Q1 FY2018 | Mar 31, 2018 | $6.55B | +1.3% |
| Q4 FY2017 | Dec 31, 2017 | $6.57B | +0.7% |
| Q3 FY2017 | Sep 30, 2017 | $6.52B | – |
| Q2 FY2017 | Jun 30, 2017 | $6.51B | – |
| Q1 FY2017 | Mar 31, 2017 | $6.47B | – |
| Q4 FY2016 | Dec 31, 2016 | $6.52B | – |
See a number that looks wrong?